Caplin Point Laboratories

Caplin Point is a fully integrated pharmaceutical company from India, operating with a unique business model focused on creating value for its stakeholders. The company's vision is to achieve significant growth by choosing unconventional markets and serving underserved customers, particularly at the 'Bottom of the Pyramid'. A key part of its strategy is maintaining a strong, integrated distribution network which allows for direct market access and consistent growth. It produces a diverse portfolio of over 650 pharmaceutical formulations across 36 therapeutic segments, covering a majority of the WHO's essential drug list. By venturing into some of the world's toughest geopolitical markets, Caplin has gained a significant first-mover advantage that is difficult for competitors to replicate. This approach has driven remarkable financial performance, growing its revenue ten times from ₹177 Crores in FY14 to ₹1761 Crores in FY24.;